Volume 8, Number 10, October 2002

Bioterrorism-Related Anthrax

A Two-Component Direct Fluorescent-Antibody Assay for Rapid Identification of Bacillus anthracis

Barun K. De,* Sandra L. Bragg,* Gary N. Sanden,* Kathy E. Wilson,* Lois A. Diem,* Chung K. Marston,* Alex R. Hoffmaster,* Gwen A. Barnet,* Robbin S. Weyant,* Teresa G. Abshire,† John W. Ezzell,† and Tanja Popovic*
*Centers for Disease Control and Prevention, Atlanta, Georgia, USA; and †U.S. Army Medical Institute of Infectious Diseases, Fort Detrick, Maryland, USA

Figure. Direct fluorescent-antibody (DFA) staining of Bacillus anthracis cells. Panel A (cell wall DFA) and Panel B (capsule DFA) correspond to 1) Positive control (B. anthracis Pasteur strain), 2) Test isolate #2002013601 (environmental specimen, 2001 U.S. anthrax outbreak), and 3) Clinical specimen #2002007069 (lung tissue of patient 1, 2001 U.S. anthrax outbreak), original magnification x 400.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed September 17, 2002

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention